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OXYGEN THERAPY IN OPHTHALMOLOGY: A REVIEW OF THE 
LITERATURE AND PRELIMINARY EXPLORATION OF ITS EFFICACY IN 
TREATING OCULAR ISCHEMIA 
ARVIND BALASUNDARAM 
ABSTRACT 
Background: Oxygen therapy has been widely used for a variety of systemic conditions. 
The ischemic basis of many ocular conditions provides a basis for oxygen’s application 
in this area as well.  
Review: Literature was reviewed to evaluate the efficacy of oxygen therapy in treating 
inner retinal ischemia (diabetic retinopathy, vein occlusions, artery occlusions, and 
radiation retinopathy), outer retinal ischemia (retinal detachment, macular holes, and 
macular degeneration), nerve ischemia (ischemic optic neuropathy, diabetic papillopathy, 
and ischemic third nerve palsy), and ocular ischemia (ocular ischemic syndrome and 
retinopathy of prematurity). Published studies support the use of oxygen for a range of 
ocular conditions including diabetic retinopathy, retinal detachments, and macular holes. 
For other conditions where autoregulation may limit flow during hyperoxia, isocapnic 
hyperoxia provides a method to circumvent these limitations.  
Methods: One radiation retinopathy patient received a three-hour normobaric hyperoxia 
trial. Oxygen was delivered by an oxygen concentrator through a face mask at a rate of 
five liters per minute. Early Treatment Diabetic Retinopathy Study (ETDRS) visual 
acuity, contrast sensitivity, intraocular pressure, and optical coherence tomography 
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testing were obtained immediately preceding and following the trial to determine any 
changes.  
Results: The results show slightly improved ETDRS visual acuity and contrast 
sensitivity score. Retinal edema in the area of greatest thickness showed a decrease of 
3.1%, a larger change than would be expected in a healthy, control eye.  
Conclusions: The results of the three-hour normobaric hyperoxia trial suggest that 
oxygen is effective in reducing retinal edema. Visual acuity was not impacted as greatly, 
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 Oxygen plays a critical role in cellular metabolism. The presence of oxygen 
allows the metabolic pathway to proceed through oxidative phosphorylation. Functionally 
it serves as the final electron acceptor in the electron transport chain due to its high 
electronegativity. Its role at the end drives forward the entire process ahead of it, 
including the citric acid cycle and the prior stages of the electron transport chain. Given 
that aerobic respiration is roughly eighteen times as efficient compared with anaerobic 
respiration in generating a fundamental energy storage molecule, ATP, the importance of 
oxygen in life as we know it cannot be understated.  
 Though oxygen was discovered in the 18th century, it only entered mainstream 
clinical use in the early 20th century. Following the discovery of the hypoxic state of the 
human body as well as the instruments of delivery, oxygen began to be used 
therapeutically for chronic lung disease (Heffner, 2013). Early studies showed mixed 
results for the then-expensive treatment but large, multi-center trials starting in the 1970s 
supported oxygen’s efficacy in treating Chronic Obstructive Pulmonary Disease (COPD) 
(Heffner, 2013). This established oxygen as a therapeutic measure.  
Oxygen currently has a variety of therapeutic uses in medicine. Long term oxygen 
therapy (LTOT) continues to be a major, effective treatment for severe COPD, a disease 
caused by airway constriction and inflammation resulting in difficulty breathing (Cazzola 
et al., 2007). Pulmonary fibrosis occurs due to scarring and stiffening of lung tissue 
similarly increasing the difficulty to breathe and thus supplemental oxygen is prescribed 
to maintain oxygen levels (Graney et al., 2017). High flow oxygen has been shown to 
	
2 
decrease 90-day mortality rates for acute respiratory failure (Frat et al., 2015). It is also 
the standard practice for hypoxemic cases of acute heart failure (Sepehrvand and 
Ezekowitz 2016).  
 
 
Figure 1: Normobaric and Hyperbaric Oxygen Delivery. Oxygen concentrator (left) 
used to generate normobaric oxygen used therapeutically for conditions such as COPD. 
Hyperbaric chamber (right) used to deliver oxygen at pressures greater than atmospheric. 
Images from Koninklijke Philips N.V. (left) and St. Vincent (right).  
 
Hyperbaric oxygen therapy (HBOT) involves the use of 100% oxygen inside a 
chamber with pressures higher than 1 atmosphere. HBOT is the most effective treatment 
to prevent death and restore oxygenation to the tissues in decompression sickness that 
occurs when divers ascend rapidly and bubbles form in the circulation (Lam and Leung, 
2018). HBOT also counters the hypoxia caused by carbon monoxide poisoning, along 
with a variety of side effects caused by carbon monoxide (Lam and Leung, 2018). 
Hyperbaric chambers are also used to assist wound healing of chronic diabetic foot ulcers 
(Ont Health Technol Assess Ser, 2017). HBOT is most effective for wounds infected 
with oxygen-consuming bacteria, indicating that the therapy helps restore required 
oxygen levels (Flegg et al., 2010). Topical oxygen therapy, delivered directly to the 
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wound site, is a new area of development that has been shown in one study to 
significantly improve the rate of healing of diabetic foot ulcers (Yu et al., 2016). There is 
some evidence to support that HBOT may be an effective treatment option for migraine 
headaches and the associated nausea and vomiting (Bennett et al., 2015).  
As such, oxygen is an established standard treatment for a wide variety of 
conditions. Though it is abundant in nature, it is nonetheless a drug used in the clinical 
setting and must be used with caution as there may be adverse effects from excessive 
exposure (Sepehrvand and Ezekowitz 2016). When considering oxygen therapy, all the 
benefits and risks must be weighed carefully.  
Healthy Ocular Circulation  
The two major components of circulation in the eye are the retinal and ciliary 
vessels. All blood flow derives from the internal carotid artery through the ophthalmic 
artery which splits into the central retinal artery as well as several posterior and anterior 
ciliary arteries. The inner two-thirds of the retina are nourished from the retinal 
circulation from the branches of the central retinal artery while the outer one-third 
depends on the ciliary circulation from the choroid. As such, both circulations are 
necessary for adequate nutrition of all layers of the retina. 
Retinal circulation has comparatively lower flow than the ciliary circulation but 
has the capability for autoregulation. These arteries and veins are located within the nerve 
fiber layer of the retina. These arteries have no anastomoses and thus any occlusion will 
result in damage to the cells of the inner retinal layers.  
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Choroidal flow occurs in the ciliary vessels. There is a higher overall flow, but 
these vessels lack the ability to autoregulate. The increased flow results in several effects: 
a lower percentage of oxygen being extracted from the blood, high oxygen tension to 
assist diffusion, and thermal protection for the eye.  Shunts exist among medium and 
large choroidal arteries to prevent damage from occlusion but blockages in arterioles will 
result in damage to the outer retinal layers. The optic nerve derives its circulation from a 
variety of sources including branches of the central retinal artery, pial vessels, choroidal 
arteries, and posterior ciliary arteries.   
 
Figure 2: Retinal Circulation. Retinal circulation derives from the central retinal artery 
which travels within the optic nerve to nourish the inner retina. Ciliary arteries enter the 
choroid where the provide circulation for the outer part of the retina. Image from Kur et 
al.    
Venous blood from the retinal circulation drains through the central retinal vein 
located within the optic nerve. Choroidal venous blood exits via the vortex veins, located 
in each quadrant.   
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As the eye is one of the only locations in the body where the vasculature is easily 
visible, it presents a unique opportunity to visualize and measure blood flow. In the 
animal model, techniques include direct cannulation of veins to directly measure flow, 
labeled microspheres, vitreous oxygen tension recording, and glucose consumption as a 
proxy for metabolic demands. In humans, fluorescein angiography for retinal circulation, 
indocyanine green angiography for choroidal circulation, and laser doppler velocimetry 
for blood flow are all imaging techniques used clinically to evaluate blood perfusion and 
flow.  
The pressures associated with circulation in the eye can be difficult to determine 
accurately in the human model. Venous pressure is best approximated by the intraocular 
pressure which has a normal range around 15 mm Hg. Arterial pressure in the eye is 
around 60 to 70 mm Hg, estimated based on an internal carotid mean arterial pressure of 
80 mm Hg and extrapolating the subsequent pressure drop due to resistance from rabbit 
and monkey models. This results in a perfusion pressure of around 50 mm Hg. 
(Information in this section from Adler’s Physiology of the Eye: Clinical Application).  
Autoregulation 
Autoregulation refers to the ability of blood vessels to constrict or expand to 
maintain a stable flow rate in the face of changes in perfusion pressure. This occurs 
almost entirely based on local factors instead of systemic control. The lower limit for the 
retinal circulation to maintain adequate flow is around 30 mm Hg. Autoregulation fails to 
protect from increases in blood pressure when they exceed 140% of normal. Two 
mechanisms contribute to autoregulation. The myogenic response is triggered by 
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transmural pressure changes and results in altered arterial tone and resistance. When 
transmural pressure decreases, vasodilation results. The metabolic response results from 
local factors, such as the metabolic end product, CO2, signaling vasodilation to receptive 
arterial muscle cells. On the opposite end, increased pressure and flow creates a 
vasoconstriction response to ultimately moderate oxygen levels in the retina. The 
choroid, which lacks the mechanisms of autoregulation, is much more sensitive to 
changes in arterial and intraocular pressure.  
 
Figure 3: Autoregulation. Autoregulation stabilizes blood flow across a moderate range 
of perfusion pressure changes. Image from He et al.  
 
A study by Arciero et al. in 2013, attempted to create a mathematical model to 
best predict the importance of the factors controlling autoregulation in the retina. They 
found that metabolic indicators and CO2 levels were the most important for 
autoregulation (Arciero et al., 2013).   
Isoxic hypercapnia consists of room air with elevated CO2 levels. Roff et al. in 
1999 compared room air with isoxic hypercapnia to determine changes in ocular 
hemodynamics, essentially looking at the effects of increased CO2 concentration. With a 
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total of fourteen subjects, both sets of measurements were conducted on all participants to 
serve as a control. Using color doppler imaging, scanning laser doppler flowmetry, and 
ocular blood flow, measurements of blood flow, volume, and velocity were acquired for 
each quadrant of the peripapillary retina. Hypercapnia was found to increase blood flow, 
volume, and velocity in the superior temporal quadrant while leaving pulsatile ocular 
blood flow unaffected (Roff et al., 1999). This seems to suggest that hypercapnia itself 
could increase blood flow in the eye and may be useful when attempting to increase 
blood flow to the retina.   
Carbogen is a commercially available mixture, normally 5% CO2 and 95% O2. A 
study by Berkowitz in 1996 sought to determine if carbogen oxygenates the inner retina 
more effectively than 100% O2 in a murine model.  Carbogen was thought to potentially 
prevent the autoregulatory vasoconstriction that normally occurs with 100% O2. The 
gases were delivered at 2.5 liters per minute and alternated on the same subjects after a 
ten-minute rest period. Raw MRI data was converted to represent partial pressure of 
oxygen (PO2). The pre-retinal vitreous PO2 was assumed to correlate to inner retinal PO2. 
At the systemic level, carbogen altered PCO2 and pH, but not PO2. Carbogen did, in fact, 
increase oxygenation to the inner retina by a factor of 1.47 compared with 100% O2 in 






 The goal of this study is to (1) review the current literature on the therapeutic use 
of oxygen in treating ocular ischemia, (2) present the methods of a pilot study employing 
normobaric hyperoxia treatment for ocular ischemia, and (3) present a case study from 
the pilot study trial.  
Normobaric hyperoxia is the delivery of elevated concentration of oxygen at 
normal atmospheric pressure. The vast majority of current research has concerned 
hyperbaric treatment. Given the higher cost and risk associated with hyperbaric 
treatment, it is important to evaluate if normobaric oxygen treatment could be an 







Inner Retinal Ischemia 
 Ocular disorders can have a major impact on the delicate balance of the 
circulation system and on vision.  Conditions of inner retinal ischemia concern the retinal 
circulation system. Damage or occlusion of these vessels leads to ischemia, photoreceptor 
cell death, and vision loss.  
Diabetic Retinopathy 
Diabetic retinopathy (DR) is a condition caused by blood vessel changes and 
damage occurring in diabetics. Starting with non-proliferative diabetic retinopathy 
(NPDR), the blood vessels in the eye leak due to damage from high blood sugar. The 
leaking fluid creates macular edema (ME) and areas of ischemia. NPDR progresses to 
proliferative diabetic retinopathy (PDR), where the ischemia has worsened to the degree 
that new vessels are created. These new vessels are weak and accelerate the process of 
edema and hemorrhage. Given the increasing prevalence of diabetes globally, 




Figure 4: Diabetic Retinopathy. The changes occurring during diabetic retinopathy 
include edema and leakage in NPDR. Progression to PDR occurs with the growth of 
abnormal blood vessels. Image from VMR Institute.  
 
Macular edema prevents retinal cells to have adequate access to nutrition from 
blood vessels. This leads to blurry vision and damage to the cells.  A potential factor in 
this edema has been shown to be the induction of Aquaporin-0 due to diabetes as 
demonstrated in a murine model (Fukuda 2011). This additional mechanism for edema 
may exacerbate the ischemia experienced by cells in the retina. The neovascularization 
which follows can also lead to scar tissue formation, further impacting vision and causing 
retinal detachments.  
The signaling pathway used by the photoreceptor cells is unique in that it is 
deactivated in the presence of a stimulus (light). Thus, the pathway is kept open in 
darkness resulting in oxygen consumption. It has been theorized that increasing exposure 
to light during periods of darkness, such as sleep, may reduce oxygen demand, ischemia, 
and ultimately macular edema. CLEOPATRA was a large-scale study evaluating the 
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efficacy of a light mask in decreasing diabetic macular edema. After two years, however, 
no significant decrease in diabetic macular edema was observed (Sivaprasad et al., 2018).  
The current standard treatments for PDR are laser treatments and anti-VEGF 
injections. Vascular endothelial growth factor (VEGF) is an essential part of the signaling 
cascade that results in new blood vessel formation. Anti-VEGF therapy injects antibodies 
to the VEGF protein, preventing the formation of new vessels. This approach has been 
effective, and Avery et al. shows Bevacizumab regressing neovascularization 
successfully and preventing all leakage in 73% of patients (Avery et al., 2006). While the 
effects of the injection began as soon as twenty-four hours of administration, recurrence 
was a potential issue. One patient was seen to have leakage as soon as two weeks post-
injection, but another still had none at the eleven-week follow up (Avery et al., 2006). 
Thus, treatment of many patients requires repeated injections. Supplemental therapies 
such as oxygen may be beneficial to reduce this burden.  
Targeting treatment effectively requires a thorough understanding of the 
mechanism of disease. For DR, the central issue is ischemia. Retinal oximetry, as used in 
a study by Jorgensen et al. in 2004, measures oxygen concentration within ocular blood 
vessels. They found that as DR progressed through its stages, its severity was correlated 
with increased oxygen saturation in venules and thus decreased oxygen extraction in 
NPDR. In PDR, the disease progression led to increased arteriolar saturation as well, 
bringing back normal extraction. They could not conclude whether these changes were a 
result of DR or if they contributed to the progression of DR (Jorgensen et al., 2014). 
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Nevertheless, these results show that significant changes occur to blood vessels and flow 
in DR and that ischemia increases during the progression of NPDR.  
 
Figure 5: NPDR Oxygen Saturation. Arterio-venous saturation and extraction 
decreased significantly during the progression of NPDR. Image from Jorgensen et al.  
 
A review by Bek published in 2017 found that, across studies, diabetics have a 
decreased response in blood vessel diameter autoregulation compared with healthy 
patients. Diameter is used as a proxy for retinal blood flow. Exact results, however, 
varied, and thus measurements were best when comparing across time in the same patient 
(Bek 2017). This knowledge of decreased autoregulation in diabetics may be critical in 
treating DR. Given that the primary pathology in DR is ischemia, the decreased 
autoregulation would result in higher than normal blood flow. This may translate to an 
increased ability to deliver oxygen therapeutically to counteract the effects of ischemia.  
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Harris et al. in 1996 studied whether hyperoxia would aid vision in patients 
affected with DR. Twelve diabetic patients with minimal retinopathy and twelve controls 
were included. Breathing normal air, the diabetics showed decreased contrast sensitivity 
compared with healthy subjects. All experimental subjects then received isocapnic 
hyperoxia for fifteen minutes, followed by fluorescein angiography and contrast 
sensitivity testing. It was found that this treatment increased contrast sensitivity up to 
normal levels for diabetics without changing blood flow. Conversely, blood flow 
decreased in the healthy controls, suggesting a decreased autoregulatory mechanism in 
diabetics. The decreased contrast sensitivity may be reversible as long as the cause, 
ischemia, is rectified (Harris et al., 1996).  
 
Figure 6: Hyperoxia and Contrast Sensitivity. Contrast sensitivity in diabetics 
breathing room air and after 15 minutes of isocapnic hyperoxia. The treatment 
significantly improved contrast sensitivity at the twelve cycles per degree spatial 
frequency. Image from Harris et al.  
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 Looking at diabetic macular edema specifically, ischemia and high levels of 
VEGF are associated with the microaneurysms that are the sources of the edema. Nguyen 
et al. showed that oxygen therapy in the long term can decrease ME. (Nyugen et al., 
2004). After receiving four liters per minute of oxygen continuously for three months, the 
patients showed a range of responses to the treatment, with higher initial retinal 
thicknesses, and thus edema, correlated with greater decreases. Visual acuity, however, 
did not significantly change. These results suggest that ischemia is a factor in macular 
edema, but a broader, more controlled study may be needed to elucidate the effects of 
oxygen therapy.  
Vein Occlusion  
 Vein occlusions in the eye occur in either the central retinal (CRVO) or branch 
retinal (BRVO) veins. Frequently caused by atherosclerosis, these near-complete 
blockages prevent drainage of blood leading to hemorrhages and edema. Other 
complications can include neovascularization and glaucoma. Primary treatments include 
anti-VEGF injections to stop neovascularization, corticosteroid injections to limit edema, 
laser treatment to stop leakage, or a combination therein.  
 There have been experimental approaches to eliminate the ischemia caused by the 
occlusion. It is possible to implant an electrode directly into the vitreous chamber which 
fills the eye (Abdallah et al., 2011). As current passes through the wire, electrolysis of the 
water-rich vitreous humor generates oxygen. In the rabbit experiment, postmortem testing 
revealed that the oxygen treatment prevented a large part of the damage from ischemia. 
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The treated eyes showed less atrophy of the retina and retinal pigment epithelium (RPE) 
as well as fewer markers of damage from oxidative stress (Abdallah et al., 2011).  
 In humans, Miyamoto et al. used hyperbaric oxygen on a mix of CRVO and 
BRVO cases. In this early experiment, the protocol was not standardized, and exposure 
varied to the oxygen varied greatly. Immediately post-treatment, visual acuity improved 
particularly for BRVO cases as opposed to CRVO (71% and 44% respectively). Six 
months later, BRVO patients had an overwhelming advantage for effect persistence (47% 
vs 9%). The best prognosis for this treatment occurred in younger patients who started 
with better pre-treatment visual acuity (Miyamoto et al., 1993).  
Artery Occlusion 
 Retinal artery occlusions are obstructions of the central retinal (CRAO) or branch 
retinal (BRAO) arteries. Onset is rapid and results in quick vision loss. Immediate 
medication and surgery can help reduce vision loss, but full recovery is rare. In a meta-
analysis, Wu et al. (2018) compared seven studies using a variety of oxygen treatments 
for CRAO and BRAO and a total of 251 patients. Their analysis confirmed the efficacy 
of oxygen therapy in treating this condition. The results indicate that 100% hyperbaric 
oxygen for at least nine hours would be more effective that normobaric, short-term, or O2 
-CO2 mixed alternatives (Wu et al., 2018).  
Radiation Retinopathy 
 The two major types of primary ocular cancers are melanomas and non-Hodgkin 
lymphoma, with the most common being choroidal melanoma. The main treatment 
modality for this cancer is radiation therapy. Versions of this treatment have metastatic-
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free survival rates higher than 88%, but side effects such as radiation retinopathy are 
common, with an occurrence rate of 43% in one study (Le et al., 2018). This treatment 
results in retinal perfusion changes due to the radiation compromising the endothelium of 
ocular blood vessels, creating leakage. These changes, which resemble DR, can cause 
significant alterations to oxygenation of the retina, as seen by Wu et al. (2018). In a study 
of unilateral radiation patients, Optical Coherence Tomography (OCT) and Hyperspectral 
Retinal Camera were used to measure blood flow and oxygen saturation. The 
presentation of the patients allowed the other eye to be used as a control. Blood flow was 
found to be significantly decreased in the affected eye whereas oxygen saturation was 
higher. This may be due to decreased oxygen demand from cell death or as a result of 






Outer Retinal Ischemia 
 The conditions leading to outer retinal ischemia concern the second major 
circulation in the eye, the ciliary system. Since the outer one-third of the retina that 
requires nutrition from the choroidal circulation contains the photoreceptor cells, 
disorders in this system can result in a major impact on vision.  
Retinal Detachment 
The retina contains the photoreceptor cells necessary for vision. Retinal 
detachment is a serious condition resulting from the separation of the retina from the 
underlying RPE and choroid. When the retina lacks close access to nutrients from the 
blood, cell death and permanent loss of vision can ensue. The major types of retinal 
detachment are rhegmatogenous, tractional, and exudative. The most common form is 
rhegmatogenous which result from a tear in the retina allowing fluid to leak behind the 
tissue. The overall prevalence of this type of retinal detachment is between 6.3 and 17.0 
per 100,000 (Mitry et al., 2010). Another study shows that while rates of retinal 
detachment were roughly similar for many decades, there have been noticeable increases 
since the 1990s, primarily in diabetics (Shah, Hall, & Goldacre, 2015). Given that the 
incidence of diabetes is increasing, it is likely that the prevalence of retinal detachment 





Figure 7: Retinal Detachment. Retinal detachments occur when a break allows fluid to 
enter the space behind the retina, separating it from the underlying, blood vessel-rich 
choroid. Image from Retina Associates, Kansas City, MO.  
 
The primary treatment for retinal detachment is a variety of surgical techniques 
which reattach the retina to the RPE, including cryopexy, scleral buckle, and vitrectomy 
among others. The success rates for these surgeries are roughly between 80-96% 
(Wubben et al., 2016). While additional surgeries can improve the rates of successful 
attachment, the return of visual capability does not always occur (Wubben et al., 2016). 
Thus, additional treatment methods should be explored to increase the percentage of 
successful rehabilitation of sight.  
One of the earliest integrations of hyperoxia treatment was at Mount Sinai 
Hospital where it was observed that patients with sickle cell disease commonly developed 
retinal detachments and that surgeries lacked efficacy, potentially due to the shape of the 
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blood cells (Freilich & Seelenfreund, 1973). The modification made was to conduct the 
surgeries in a hyperbaric operating theater with oxygen pressure at two atmospheres, pre-
anesthesia. Among the four cases examined in the study, all resulted in successful 
reattachment using the scleral buckle method with none of the previous issues common in 
sickle cell patients (Freilich & Seelenfreund, 1973). While the sample size is small in this 
case study, the results show that this treatment option may have benefits for at least 
certain indications, such as sickle cell anemia. 
Oxygen supplementation has been explored significantly in the feline model in 
attempts to determine the mechanisms by which it assists in successful retinal 
reattachment. In one study, after surgically induced retinal detachment, hyperoxia was 
shown to prevent the death of photoreceptor cells, as well as to maintain enzyme and 
protein activity (Mervin et al., 1999). Since retinal detachment decreases the availability 
of oxygen to photoreceptor cells, it is possible that the increased concentration of oxygen 
is enough to prevent an apoptotic response (Mervin et al., 1999). Another study by Wang 
and Linsenmeier (2007) examined the distribution of oxygen among the layers of the 
retina under normal conditions, after retinal detachment, and in a detached retina after 
100% oxygen. The results show that the oxygen supplementation increases the level of 
oxygen at the edge of the retina to levels around normal, compensating for the loss that 
occurs across the fluid layer that separates the outer retina from the choroid during a 
retinal detachment. While the oxygen levels returned to normal in the outer retina 
following treatment, oxygen use by photoreceptors remained below normal levels (Wang 
& Linsenmeier, 2007). A third feline study offers a potential explanation: delayed 
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hyperoxia preserved photoreceptor cells but did not stop the hypertrophy of glial cells 
that also occurs during retinal detachment (Lewis et al., 2004). It is possible that these 
enlarged cells may be consuming some of the oxygen, limiting the quantity available. 
Macular Holes 
 The macula is located at the center of the retina and is an area of concentrated 
photoreceptor cells. Damage to this area will affect color, high-resolution, well-lit vision. 
Macular holes occur when a break develops in the retina in this area. There are three 
stages of macular holes. Stage 1 is a foveal detachment. 50% of untreated patients 
progress to a partial-thickness hole (Stage 2). The final stage is a full-thickness macular 
hole (Stage 3) which will occur is 70% of untreated stage 2 patients. The most frequent 
cause of this condition is the posterior aspect of the vitreous detaching from the retina. 
While this is a normal part of the aging process, in some cases, the tension from the 
detachment will cause a macular hole. Treatment for this condition is most frequently a 
vitrectomy surgery.  
 A concerning complication of this surgery is temporal visual field defects. This 
may be a result of alterations to the chorioretinal circulation (Kurok et al., 2002). In a 
study, patients with these visual field defects had an average of 71.9% of their 
preoperative visual field. Following delivery of hyperbaric oxygen for 110 minutes per 
day for twenty days, improvements were seen rapidly and significantly. Within three 
days, the treatment group average rose to 81.7% and progressed to 91.6% at the six-
month mark, while no changes were observed in the control group (Kurok et al., 2002). 
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This evidence strongly supports both the ischemic basis for the complication as well as 
the potential of oxygen therapy to restore function.  
Macular Degeneration 
 Another condition concerning the macula is Age-related Macular Degeneration 
(AMD). It primarily affects older individuals, but the pathogenesis and risk factors are 
not clear. The main indicator of AMD is the presence of drusen, yellow deposits in the 
retina. As AMD progresses through its three stages, more and larger drusen are present, 
concurrent with worsening vision. In the final stage, vision is impacted, particularly in the 
central field. This stage can either be dry or wet. Wet AMD occurs when 
neovascularization accompanies cell death and vision loss. While there is no known cure 
for AMD, most early and dry forms are treated with the AREDS2 vitamin formula, 
derived from clinical trials on the topic. The most common treatment for wet AMD is 
anti-VEGF injections, similar to other neovascular conditions.  
 When comparing oxygen saturation of AMD patients to healthy controls, 
Geirsdottir et al. (2014) found that progression of the disease is correlated with increased 
venous oxygen content as well as a decreased arterio-venous saturation difference. This is 
the opposite of what was observed in the control patients. These findings seemingly 
indicate decreased oxygen consumption, possibly as a result of decreased demand due to 
cell death (Geirsdottir et al., 2014). Given the mean age of 45 in the study, however, it is 
likely that these patients were in the early stages of AMD, limiting the generalizability of 




Figure 8: AMD Oxygen Saturation. AMD patients show a trend of increasing oxygen 
saturation in venules with age, significantly different than what is seen in healthy 
patients. This reversal is also true for the arteriovenous difference. Image from 






Optic Nerve Ischemia  
Ischemic Optic Neuropathy 
As discussed earlier, the optic nerve derives its circulation differently than the 
retina. A combination of the choroidal, pial, ciliary, and other vessels contribute to optic 
nerve perfusion. Ischemic optic neuropathy occurs when blood flow to the optic nerve is 
blocked, resulting in swelling of the optic disk and quick, painless vision loss. The two 
major forms are arteritic (AION) and nonarteritic (NAION), with the arteritic variant 
involving inflammation of the blood vessels as well. NAION is the most common version 
and is idiopathic. AION occurs in older patients and is frequently a complication of giant 
cell arteritis. In either case, there is no clear treatment path, and the visual prognosis is 
not promising.   
Systemic corticosteroids are the most frequent treatment modality for NAION, 
but there is still much debate about its efficacy (Al-Zubidi et al., 2014). Hyperbaric 
oxygen has been found to improve outcomes for patients not responding to steroid 
therapyin on study (Bojic et al., 1995). In a different study, hyperbaric oxygen improved 
visual acuity, but this difference was not statistically significant (Arnold et al., 1996). 
Twenty years later, in a comparison of normobaric oxygen and systemic steroids, another 
study found that neither treatment had a significant effect compared to no treatment at all 




Figure 9: Ischemic Optic Neuropathy Treatment. Neither steroids nor oxygen therapy 
had a significant improvement in best corrected visual acuity (logMAR scale). Image 
from Pakravan et al., 2016.  
 
Thus, the results suggest that neither the current standard of steroid treatment nor 
oxygen is an effective method for NAION. Both trials used a short duration of oxygen 
therapy: ten days (Arnold et al., 1996) and fourteen (Pakravan et al., 2016). Longer 
duration and more frequent therapy may have different effects. The range of results here 
for both the steroid and oxygen treatments indicate that further research must be done to 
develop an effective treatment modality for NAION. 
Diabetic Papillopathy 
Diabetic papillopathy is an optic disk swelling caused by leakage and edema, 
affecting both type 1 and type 2 diabetics. Outcomes are generally good, particularly with 
injections of corticosteroids or anti-VEGF drugs (Giuliari et al., 2011). Diabetic 
papillopathy can be considered a mild variant of NAION (Hayreh, 2002). In a 
	
25 
retrospective analysis, Ostri et al. (2010) found that patients were more likely to develop 
diabetic papillopathy with a trend of decreasing HbA1C and with a small cup to disk 
ratio. This seems to indicate that quick resolution of hyperglycemia may increase the risk 
for diabetic papillopathy. The decreased autoregulation seen in diabetics may make these 
patients more vulnerable to increased blood flow that occurs along with decreased blood 
sugar after insulin administration (Ostri et al., 2010). This theory fits with other studies 
showing that rapid control of blood sugar, such as a greater than two percent decrease in 
HbA1c, is associated with progression of DR (Funatsu et al., 1992). A potential treatment 
has been shown to be effective is the combination of laser and anti-VEGF injections 







Peripheral Nerve Ischemia 
Ischemic Third Nerve Palsy 
 Cranial nerve three, the oculomotor nerve, controls the medial, inferior, and 
superior rectus and the inferior oblique muscles. Ischemic third nerve palsy results in 
paralysis of those muscles, closed eyelid, diplopia, and an external, downward rotation of 
the affected eye. Similar palsies can affect the other major eye movement nerves, cranial 
nerves four and six. These are frequently caused by lesions in the nerve but may also 
result from microvascular ischemia. A team of neuro-ophthalmologists used magnetic 
resonance imaging (MRI) = to determine the cause of third, fourth, and sixth cranial 
nerve palsies (Tamhankar et al., 2012). 91 of the 109 total patients had an ischemic cause, 
with 83 of those patients having vasculopathic risk factors such as diabetes, smoking, etc. 
(Tamhankar et al., 2012). Given the ischemic basis of this condition, further research 
should be conducted to evaluate the potential efficacy of oxygen therapy to supplement 










Ocular Ischemic Syndrome  
 Ocular ischemic syndrome (OIS) occurs as a result of stenosis or occlusion of the 
carotid artery. Since all of the blood vessels supplying the eye and orbit derive from the 
internal carotid, this condition can result in severe visual impairment. OIS may present 
similar to DR or CRVO but requires both local and systemic treatment (Terelak-Borys et 
al., 2012). Studies of the mechanism show that cytokines, kallidinogenase and endothelial 
nitric oxide synthase, have possible protective effects for retinal ischemia (Masuda et al., 
2014). Specific use of oxygen therapy for OIS has not been explored.  
Retinopathy of Prematurity  
Retinopathy of prematurity is an ischemic syndrome affecting premature infants. 
Ocular circulation is significantly different during development. It derives primarily from 
the hyaloid artery until it regresses after the normal vasculature develops. In preterm 
infants, the normal circulation may not be fully developed. The sudden demand in 
oxygen by the retina results in a neovascular cascade creating edema and hemorrhage. 
Similar to other conditions with neovascularization, the new vessels can create scar tissue 
resulting in tractional forces potentially leading to retinal detachments. There are five 
stages of ROP, increasing in severity. While most cases of ROP do not need treatment, 
severe cases will result in loss of vision. Treatments include laser photocoagulation and 
anti-VEGF injections. Laser treatment has become an increasingly used alternative to 




As mentioned in Hellström et al. (2013), the early uses of oxygen therapy actually 
contributed to the incidence of ROP. Hyperoxia prevented the full growth of retinal 
vessels and its subsequent removal resulted in a state of hypoxia and vasoproliferation. 
Recent developments have controlled the use of oxygen and dosage, preventing this 
outcome (Hellström et al., 2013). This situation serves to indicate the importance of 






CASE STUDY  
A 49-year old Caucasian male presented with radiation retinopathy in his left eye 
as a result of treatment for choroidal melanoma. A three hour, normobaric hyperoxia trial 
was conducted to determine if this treatment would deliver any changes in edema or 
visual acuity.  
Methods 
Before the trial, a series of tests and imaging was conducted to establish a 
baseline. Visual acuity was determined using a Precision Vision Original Series ETDRS 
Chart R with an ETDRS Illuminator Cabinet. This testing option offers higher test-retest 
reliability and accuracy than the conventional Snellen chart (Shamir et al., 2016). Testing 
was conducted at a distance of four meters and a standard illumination of 85 candelas per 
square meter. All other light sources were turned off. Vision was taken with the use of 
prescribed corrective lenses as well as with pinholes in order to obtain the best possible 
visual acuity. 
Contrast sensitivity was tested using the Vector Vision CSV-1000E. This model 
provides testing of spatial frequencies 3, 6, 12, and 18 cycles per degree with contrast 
decreasing at logarithmic increments. The chart was also illuminated at 85 candelas per 
square meter. This chart also offers a high level of test-retest reliability (Pomerance and 
Evans, 1994). Figure 10 shows a sample of the chart. Patients were instructed to select 
the appropriate circle with lines. The final column without failure to do was noted. Scores 





Figure 10: Contrast Sensitivity Chart. The CSV-1000E chart has four rose with each 
row representing a spatial frequency (3, 6, 12, 18 cycles per degree) and each subsequent 
column showing a logarithmic decrease in contrast. Image from Vector Vision.  
 
 Intraocular pressure was measured using a handheld tonometer (Reichert Tono-
Pen AVIA). Finally, optical coherence tomography (OCT) was conducted using the 
Heidelberg Spectralis device. Fast raster, horizontal line, vertical line, star, and 7-line 
raster scans were obtained for each eye. The fast raster scan was used to calculate 
thicknesses using an ETDRS subfield arrangement (Figure 11). Thickness was calculated 
from the internal limiting membrane to Bruch’s membrane and then averaged in each of 
the nine subfields. In the case of this patient, the primary area of swelling was not in the 
macular but instead located in the supra-nasal region. The ETDRS subfields were 
relocated within the software to have the central subfield centered on the area of maximal 




Figure 11: OCT with ETDRS Subfields. Image shows the normal orientation of 
ETDRS subfields centered on the macula using a fast raster OCT image. Orientation of 
the subfields was shifted for this trial. Image from Açmaz et al., 2014.  
 
Following imaging, the patient began the trial oxygen treatment, consisting of 
three hours of normobaric hyperoxia. Oxygen was delivered at five liters per minute by a 
Phillips Respironics Everflo Oxygen Concentrator through an Allied Simple Medium 
Concentration Oxygen Mask. Following the three-hour period, visual acuity testing and 






 Following three hours of normobaric hyperoxia, several changes were observed. 
ETDRS visual acuity increased in the affected eye from 20/63-2 to 20/63+1, a net change 
of three letters, seen with the use of pinholes. These Snellen notation scores convert to 
logMAR scores of 0.54 to 0.48. The observed logMAR change of 0.06 is not significant 
as studies have shown the test-retest variability 95% confidence interval of an ETDRS 
charge to be ±0.14 (Lim et al., 2010). The unaffected eye showed no change, with the 
ETDRS visual acuity at the 20/20 level before and after the trial.  
Contrast sensitivity increased at the spatial frequency of three cycles per degree 
from 1.17 to 1.34 log units, while the spatial frequencies of six, twelve, and eighteen 
remained the same. This represents a change of 0.34 log units. This improvement is 
greater than the test-retest difference at three cycles per degree for healthy patients with 
the CSV-1000, 0.018 (Pomerance and Evans 1994).  
Table 1: Trial Results. 3-hour normobaric hyperoxia trial on radiation retinopathy 
patient.  






CS at 3, 6, 12, 18 




Pre-O2 20/80-1 20/63-2 1.17, 0.61, 0.31, 0.01 612 
Post-O2 20/63-1 20/63+1 1.34, 0.61, 0.31, 0.01 593 
 
OCT data showed that the average thickness in the central ETDRS subfield 
relocated to the area of maximal thickness decreased from 612 µm to 593 µm, a decrease 
of 3.1%. Data from non-diseased diabetics receiving the same treatment show that the 
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95% confidence interval for healthy eyes is a thickness change of -0.189% to 0.137%. 
The result from this trial lies outside of that interval.  
 
 
Figure 12: OCT Results. The post-trial fast raster OCT scan of the affected eye showed 
a decrease in edema in the area of maximal thickness. Using the shifted ETDRS subfield, 





 Oxygen has a wide range of therapeutic uses. It has been proven effective in a 
variety of pulmonary and systemic treatments. Many ocular conditions concern ischemia 
and thus hyperoxia therapy can be a useful treatment option. For conditions such as 
diabetic retinopathy, retinal detachments, and macular holes, oxygen therapy has been 
shown to improve outcomes. For inner retinal ischemia conditions, such as vein 
occlusions and artery occlusions where autoregulation has not been compromised, an 
isocapnic approach may be more effective. More research needs to be conducted for these 
conditions to determine the dosage and treatment regimen and to explore the viability of 
oxygen for diseases such as nerve ischemia.  
The results of the three-hour normobaric hyperoxia trial on the radiation 
retinopathy patient presented in this study show changes in the measured parameters of 
visual acuity, contrast sensitivity, and retinal thickness. Though the changes were the 
result of a single trial and thus cannot be determined to be statistically significant, the 
decrease in edema was outside the range of normal variability in a healthy eye and was 
similar to observed changes in trials of other ocular ischemia patients. The change is 
vision was not as drastic, but a key factor may be the location of the edema.  Since the 
photoreceptors are concentrated in the macula, there is a larger impact on vision when 
edema is located centrally. In this case, the area of edema was in the supra-nasal 
quadrant, away from the macula. This fact likely explains why the edema and its 
subsequent decrease did not have a greater impact on vision.  
	
35 
Oxygen is known to be a major factor in the pathogenesis of many ocular 
conditions. While frequently plays a role in worsening vision, many studies shown the 
efficacy of hyperoxia in aiding better visual outcomes. The results here support that 
framework. Further structured research is necessary to understand fully the ideal targets 
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